date,title,source
Oct-17-18,5 Beaten-Down Biotech Stocks to Pick Up from the Wreckage,InvestorPlace
Oct-22-18,"Analysis: Positioning to Benefit within Ligand Pharmaceuticals, AptarGroup, Unifirst, Universal, AutoZone, and Churchill Downs  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Oct-25-18,Ligand Pharmaceuticals (LGND) Gains But Lags Market: What You Should Know,Zacks
Oct-30-18,Keysight Technologies Set to Join S&P 500; Ligand Pharmaceuticals to Join S&P MidCap 400; Marcus & Millichap and Arcosa to Join S&P SmallCap 600,PR Newswire
Oct-30-18,3 Top Biotech Stocks to Buy Right Now,Motley Fool
Nov-01-18,3 Hammered Healthcare Stocks to Buy Now,Motley Fool
Nov-06-18,What Lies in Store for Ligand (LGND) This Earnings Season?,Zacks
Nov-08-18,Edited Transcript of LGND earnings conference call or presentation 8-Nov-18 2:00pm GMT,Thomson Reuters StreetEvents
Nov-08-18,Ligand Pharmaceuticals Inc (LGND) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Nov-08-18,Ligand Pharmaceuticals (LGND) Tops Q3 Earnings and Revenue Estimates,Zacks
Nov-08-18,Ligand: 3Q Earnings Snapshot,Associated Press
Nov-08-18,Ligand Reports Third Quarter 2018 Financial Results,Business Wire
Nov-09-18,"Ligand (LGND) Beats on Q3 Earnings & Revenues, Raises View",Zacks
Nov-09-18,Today's Research Reports on Trending Tickers: Ligand Pharmaceuticals and Intrexon,ACCESSWIRE
Nov-13-18,"Vernalis Research, a Ligand Company, Achieves Success Milestones in Collaboration with Daiichi Sankyo",Business Wire
Nov-14-18,Edited Transcript of LGND earnings conference call or presentation 8-Nov-18 2:00pm GMT,Thomson Reuters StreetEvents
Nov-14-18,Sermonix Pharmaceuticals to Present Three Posters Focused on Precision Medicine in the Treatment of Metastatic Breast Cancer at San Antonio Breast Cancer Symposium,GlobeNewswire
Nov-15-18,Edited Transcript of LGND earnings conference call or presentation 8-Nov-18 2:00pm GMT,Thomson Reuters StreetEvents
Nov-21-18,10 Triple-A Stocks to Buy for the Rest of 2018,InvestorPlace
Nov-28-18,Why Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Looks Like A Quality Company,Simply Wall St.
Nov-29-18,"Detailed Research: Economic Perspectives on American Tower Corporation (REIT), Ligand Pharmaceuticals, Teva Pharmaceutical Industries, Cummins, Alexander's, and Korea Electric Power  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Dec-10-18,Sermonix Announces FDA Acceptance of IND Application; Will Begin Phase 2 Trial of Lasofoxifene for Targeted Treatment of Women With ESR1 Mutations in Metastatic Breast Cancer,GlobeNewswire
Dec-12-18,Ligand Pharmaceuticals Inc. (LGND) Hedge Funds Are Snapping Up,Insider Monkey
Dec-17-18,Ligand Acquires Milestone and Royalty Rights to PTX-022 from Palvella Therapeutics,Business Wire
Dec-17-18,"Vernalis Research, a Ligand Company, Achieves Success Milestone in Collaboration with Asahi Kasei Pharma",Business Wire
Dec-18-18,Ligand Introduces 2019 Financial Outlook and Raises 2018 Financial Guidance,Business Wire
Dec-18-18,Rare disease treatment developer Palvella signs $10M funding deal,American City Business Journals
Dec-18-18,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",Benzinga
